Advances in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: Current Landscape and Future Directions

Manali Bhave, MD Triple-negative breast cancer (TNBC) accounts for 15% to 20% of all breast cancer cases1 and is characterized by aggressive disease associated with early recurrence and high mortality.…

Continue ReadingAdvances in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: Current Landscape and Future Directions